Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715557 · ClinicalTrials.gov registry record · NA
Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers
A NA study, sponsored by 3-C Institute for Social Development.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02715557 is a NA study that has completed, run by 3-C Institute for Social Development. The registered enrollment target is 17 participants.
The verdict
NCT02715557, a NA study, has completed, sponsored by 3-C Institute for Social Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
In Phase I of this SBIR project, 3C Institute (3C) developed a working prototype of an innovative computer-based coping skills educational program for adolescent substance abuse treatment completers. For Phase I, 3C developed and tested two customizable intelligent educational modules to teach coping skills in order to help adolescents avoid relapse, along with a brief instructional game for each segment. The Phase I prototype also included an online Parent Guide to inform parents about the uses and benefits of the product. Phase I R\&D provided strong support for the quality and value of the prototype as well as the viability of the proposed educational package and its promise for preventing substance abuse relapse with adolescents. Phase I results supported excellent quality of the product through high ratings of quality, appeal, and value. High feasibility and usability was also demonstrated through high ratings for ease of use, usability, and potential effectiveness. The goal of this Phase II SBIR project is to modify and expand the relapse prevention program developed in Phase I in response to customer feedback and to evaluate the efficacy of the full program with an RCT pilot clinical study. This product will be an adaptable software program for aftercare therapy. In Phase II, the investigators will build on the Phase I findings to modify and extend the existing content and develop the full program, which will include: an introductory module as well as interactive lessons and skill-building games for five coping skills modules. The Phase II product will also include a HelpCenter to support sustained, quality use of the product during commercialization.
Interventions
- BEHAVIORAL Relapse prevention program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02715557
The ClinicalTrials.gov registry entry for NCT02715557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3-C Institute for Social Development, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Relapse prevention program is the first listed.
NCT02715557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02715557 about?
NCT02715557 is a clinical study titled "Arise: An Online Relapse Prevention Tool for Adolescent Substance Abusers". In Phase I of this SBIR project, 3C Institute (3C) developed a working prototype of an innovative computer-based coping skills educational program for adolescent substance abuse treatment completers. For Phase I, 3C developed and tested two customizable intelligent educational modules to teach copin...
What is the current status of trial NCT02715557?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-09. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02715557?
The interventions under investigation include: Relapse prevention program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02715557?
This trial is sponsored by 3-C Institute for Social Development, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.